Dong Wei
CHIEF OPERATING OFFICER
CLINICAL DEVELOPMENT
TREOSBIO
United Kingdom
Biography
Dr. Wei has over 20 years of global R&D experience in biopharmaceutical and life science industries. Before joining Treos Bio, he was Global Development Leader of late stage development programs for Immunology diseases at Shire, and prior to that, he was Senior Director of Business Operation and Program Management at Johnson & Johnson Innovation Center at California, and held various R&D and business positions with increasing responsibilities at global biopharmaceutical companies including BioMarin, Elan, and Janssen. In particular, he has successfully led a number of clinical-stage programs across therapeutic areas including oncology, immunology, neurodegenerative diseases and orphan genetic diseases. Before that, he worked at Deloitte Consulting in Strategy and Operation Practice advising life science and biopharma clients, and conducted discovery research in oncology and genomics technologies at Chiron and Applied Biosystems. He has an M.B.A from the Wharton School of University of Pennsylvania, a Ph.D. in Microbiology from Michigan State University and a B.S. in Genetics from Peking University.
Research Interest
MICROBIOLOGY, PHARMACEUTICAL SCIENCES
